Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
3 Patents
#186 in Washington, DC
#186 in District of Columbia
#73,904 in US
Synergene Therapeutics, Inc.
Forward Citations = 10
7 inventors:
Washington, DC, United States of America
Synergene Therapeutics, Inc.
% Expired Patents = 66.7
CIPO Patents = 1
EPO Patents = 2
Forward Citations = 10
Loading Chart...
Loading Chart...
7 inventors (with patents filed for the assignee):
Esther H Chang (3 out of 16 patents)
Cheng-Cheng Huang (2 out of 2 patents)
William Alexander (2 out of 2 patents)
4. WenHua Tang (2 out of 2 patents)
5. Liang Xin Xu (2 out of 50 patents)
6. Joe B Harford (1 out of 1 patent)
7. Sang Soo Kim (1 out of 1 patent)
8. Wenhua Tang (0 patent)
9. Liang Xu (0 patent)
10. Wenhua Tang (0 patent)
11. Kathleen Pirollo (0 patent)
3 patents:
Company Overview
Synergene Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for genetic disorders. The company leverages cutting-edge gene editing technologies to address unmet medical needs through precision medicine. With a team of seasoned scientists and industry experts, Synergene is committed to advancing novel treatments that can improve patient outcomes. The company prioritizes collaboration with academic institutions and research organizations to accelerate the discovery and development of therapeutic solutions. Synergene’s pipeline includes programs targeting rare genetic diseases and has the potential to transform patient care in the field of genetics.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Synergene Therapeutics, Inc.. Retrieved from https://idiyas.com/company/synergene-therapeutics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]